Clinical Performance Evaluation of Four Automated Chemiluminescence Immunoassays for Hepatitis C Virus Antibody Detection
The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK | PLOS ONE
Diagnosis and Management of Hepatitis C Virus Infection - ScienceDirect
High false discovery rate of the Architect anti‐HCV screening test in blood donors in Uganda and evaluation of an algorithm for confirmatory testing - Lucey - Vox Sanguinis - Wiley Online Library
Hepatitis C virus infection and risk of liver-related and non-liver-related deaths: a population-based cohort study in Naples, southern Italy | BMC Infectious Diseases | Full Text
How to Interpret Borderline HCV Antibody Test Results: A Comparative Study Investigating Four Different Anti-HCV Assays
Core Concepts - Hepatitis C Diagnostic Testing - Screening and Diagnosis of Hepatitis C Infection - Hepatitis C Online
Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort | BMC Infectious Diseases | Full Text
Clinical pathways for patients with newly diagnosed hepatitis C – What actually happens - Irving - 2006 - Journal of Viral Hepatitis - Wiley Online Library
Diagnostic reliability of Architect anti‐HCV assay: Experience of a tertiary care hospital in India - Fletcher - 2018 - Journal of Clinical Laboratory Analysis - Wiley Online Library
Antibody screening tests variably overestimate the prevalence of hepatitis C virus infection among HIV‐infected adults in Ghana - King - 2015 - Journal of Viral Hepatitis - Wiley Online Library
Updating the Signal-to-cutoff Level to Reduce Anti-hepatitis C Virus False Positivity | Jundishapur Journal of Microbiology | Full Text
Prioritising Hepatitis C treatment in people with multiple injecting partners maximises prevention: A real-world network study - Journal of Infection
Updating the Signal-to-cutoff Level to Reduce Anti-hepatitis C Virus False Positivity | Jundishapur Journal of Microbiology | Full Text
How to Interpret Borderline HCV Antibody Test Results: A Comparative Study Investigating Four Different Anti-HCV Assays
Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort | BMC Infectious Diseases | Full Text
PDF) Performance evaluation and comparison of the newly developed Elecsys anti-HCV II assay with other widely used assays
How to Interpret Borderline HCV Antibody Test Results: A Comparative Study Investigating Four Different Anti-HCV Assays
Assessing testing rates for viral hepatitis B and C by general practitioners in Flanders, Belgium: a registry-based study | BMJ Open
Development of a risk score to guide targeted hepatitis C testing among human immunodeficiency virus patients in Cambodia
How to Interpret Borderline HCV Antibody Test Results: A Comparative Study Investigating Four Different Anti-HCV Assays
Opt-Out Panel Testing for HIV, Hepatitis B and Hepatitis C in an Urban Emergency Department: A Pilot Study | PLOS ONE
Improving engagement with healthcare in hepatitis C: a randomised controlled trial of a peer support intervention | BMC Medicine | Full Text
Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort | BMC Infectious Diseases | Full Text
